Clinical trial
Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients
NCT00271271 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00271271 |
|---|---|
| Title | Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients |
| Official title | Phase II Clinical Trial With the Combination Gemcitabine, Oxaliplatin and Vinorelbine as First Line Treatment in Patients With Non-small Cell Bronchopulmonary Cancer |
| Acronym | GON |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatine / gemcitabine / Vinorelbine |
| Enrollment | 40 |
| Start date | Jun 1, 2003 |
| Completion | Oct 1, 2006 |
| First posted | Dec 30, 2005 |
| Last update posted | Dec 7, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: